🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/06/2017 | 121,35 | 126,79 | 121,35 | 125,92 | +4,16% | 4,48% | 1.003.500 |
| 31/05/2017 | 119,54 | 121,16 | 118,52 | 120,89 | +1,67% | 2,21% | 789.000 |
| 30/05/2017 | 119,20 | 120,76 | 118,25 | 118,91 | -0,14% | 2,11% | 490.500 |
| 26/05/2017 | 118,74 | 120,38 | 118,56 | 119,08 | +0,63% | 1,53% | 561.200 |
| 25/05/2017 | 121,00 | 121,67 | 118,06 | 118,34 | -2,20% | 2,98% | 457.900 |
| 24/05/2017 | 121,35 | 121,94 | 120,46 | 121,00 | -0,38% | 1,22% | 384.900 |
| 23/05/2017 | 122,55 | 122,55 | 120,51 | 121,46 | -0,91% | 1,66% | 274.000 |
| 22/05/2017 | 122,31 | 123,50 | 121,17 | 122,57 | +0,76% | 1,90% | 375.100 |
| 19/05/2017 | 121,33 | 123,14 | 121,15 | 121,64 | +0,37% | 1,64% | 496.400 |
| 18/05/2017 | 120,01 | 121,91 | 119,59 | 121,19 | +0,24% | 1,93% | 497.900 |
| 17/05/2017 | 121,32 | 123,31 | 120,76 | 120,90 | -1,56% | 2,10% | 357.900 |
| 16/05/2017 | 122,83 | 123,94 | 121,80 | 122,82 | -0,20% | 1,74% | 379.600 |
| 15/05/2017 | 122,94 | 124,43 | 122,51 | 123,06 | -0,10% | 1,56% | 464.600 |
| 12/05/2017 | 122,47 | 123,81 | 121,64 | 123,18 | +0,78% | 1,77% | 350.900 |
| 11/05/2017 | 123,09 | 124,60 | 120,95 | 122,23 | -1,01% | 2,97% | 526.500 |
| 10/05/2017 | 125,10 | 125,47 | 122,59 | 123,48 | -1,05% | 2,30% | 625.300 |
| 09/05/2017 | 122,66 | 125,63 | 122,11 | 124,79 | +2,09% | 2,87% | 505.000 |
| 08/05/2017 | 123,22 | 123,87 | 121,65 | 122,23 | -0,50% | 1,80% | 487.100 |
| 05/05/2017 | 122,59 | 122,95 | 120,81 | 122,84 | +0,43% | 1,75% | 486.100 |
| 04/05/2017 | 122,79 | 123,58 | 121,22 | 122,32 | +0,13% | 1,92% | 333.100 |
| 03/05/2017 | 121,22 | 122,47 | 120,43 | 122,16 | +0,77% | 1,68% | 383.300 |
| 02/05/2017 | 123,25 | 124,44 | 120,06 | 121,23 | -1,44% | 3,55% | 694.900 |
| 01/05/2017 | 125,70 | 125,75 | 122,02 | 123,00 | -2,15% | 2,97% | 584.100 |
| 28/04/2017 | 121,21 | 126,15 | 120,12 | 125,70 | +4,32% | 4,97% | 1.133.200 |
| 27/04/2017 | 120,72 | 121,26 | 119,80 | 120,50 | +0,43% | 1,21% | 949.700 |
| 26/04/2017 | 116,00 | 121,32 | 112,01 | 119,99 | -1,44% | 8,03% | 1.700.300 |
| 25/04/2017 | 123,60 | 123,70 | 121,00 | 121,74 | -0,79% | 2,18% | 694.400 |
| 24/04/2017 | 122,13 | 123,09 | 120,62 | 122,71 | +1,43% | 2,02% | 863.500 |
| 21/04/2017 | 121,33 | 121,90 | 120,06 | 120,98 | -0,19% | 1,52% | 828.400 |
| 20/04/2017 | 121,03 | 121,90 | 120,55 | 121,21 | +0,35% | 1,12% | 666.800 |